Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells

Journal of the Neurological Sciences

Volumn 149, Issue 1, 1997, Pages 19-25

  Benbrik, Eric ^a   Chariot, Patrick ^a,b   Bonavaud, Sylvie ^a   Ammi Saïd, Mustapha ^b   Frisdal, Eric ^c   Rey, Christiane ^a   Gherardi, Romain ^a,b   Barlovatz Meimon, Georgia ^a  

^a FACULTÉ DE MÉDECINE   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c INSERM   (France)

Author keywords

cell culture; didanosine; lipid accumulation; mitochondria; muscle cells; zalcitabine; zidovudine

Indexed keywords

DIDANOSINE; MITOCHONDRIAL DNA; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MUSCLE BIOPSY; MUSCLE CELL; PRIORITY JOURNAL;

ANTI-HIV AGENTS; BIOPSY; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DIDANOSINE; DNA, MITOCHONDRIAL; DNA-DIRECTED DNA POLYMERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT COMPLEX II; ELECTRON TRANSPORT COMPLEX IV; HUMANS; KINETICS; LACTATES; LIPID METABOLISM; MITOCHONDRIA, MUSCLE; MULTIENZYME COMPLEXES; MUSCLE, SKELETAL; NAD(P)H DEHYDROGENASE (QUINONE); OXIDOREDUCTASES; SUCCINATE DEHYDROGENASE; ZALCITABINE; ZIDOVUDINE;

EID: 0031003145     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)05376-8     Document Type: Article

References (43)

1. Arnaudo, E., Dalakas, M.C., Shanske, S., Moraes, C.T., DiMauro, S. and Schon, E.A. (1991) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet, 337: 508-510.
2. Barlovatz-Meimon, G., Bonavaud, S. and Thibert, P. (1994) Culture of specific cell types: Muscle. In: Freshney, R.I. (ed.), Animal Cell Culture, 3rd edn., Wiley-Liss, New York, pp. 329-331.
3. Berger, A.R., Arezzo, J.C., Schaumburg H.H., et al. (1993) 2′,3′-dideoxycytidine toxic neuropathy: A study of 52 patients. Neurology, 43; 358-362.
4. Chariot, P. and Gherardi, R. (1991) Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy. Neuromusc. Disord., 1: 357-363.
5. Chariot, P., Monnet, I. and Gherardi, R. (1993) Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy. Ann. Neurol., 34: 561-565.
6. Chariot, P., Monnet, I., Mouchet, M., et al. (1994a) Blood lactate/ pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy. Arthritis Rheum., 37: 583-586.
7. Chariot, P., Ratiney, R., Ammi-Said, M., Hérigault, R., Adnot, S. and Gherardi, R. (1994b) Optimal handling of blood samples for routine measurement of lactate and pyruvate. Arch. Pathol. Lab. Med., 118: 695-697.
8. Chariot, P. and Gherardi, R. (1995) Myopathy and HIV infection. Curr. Opin. Rheumatol., 7: 497-502.
9. Chariot, P., Lamia, B., Lévy, Y., Dubreuil-Lemaire, M.L., Authier, F.J., Astier, A. and Gherardi, R. (1996) Muscle involvement in HIV-infected patients is associated with marked selenium deficiency. J. Neurovirol., 2: 24 (Abstract).
10. Chariot, P., Dubreuil-Lemaire, M.L., Zhou, J.Y., Lamia, B., Dumé, L., Larcher, B., Lévy, Y., Astier, A. and Gherardi, R. (1997) Muscle involvement in HIV-infected patients is associated with marked selenium deficiency. Muscle Nerve, in press.
11. Chen, C.H., Vazquez-Padua, M. and Cheng, Y.C. (1991) Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol. Pharmacol., 39: 625-628.
12. Chrzanowska-Lightowlers, Z.M.A., Turnbull, D.M. and Lightowlers, R.N. (1993) A microtiter plate assay for cytochrome c oxidase in permeabilized whole cells. Anal. Biochem., 214: 45-49.
13. Cooperstein, S.J. and Lazarow, A. (1951) A microspectrophotometric method for the determination of cytochrome oxidase. J. Biol. Chem., 189: 665-670.
14. Dalakas, M.C., Illa, I., Pezeshkpour, G.H., Laukaitis, J.P., Cohen, B. and Griffin, J.L. (1990) Mitochondrial myopathy caused by long-term zidovudine therapy. N. Engl. J. Med. 322: 1098-1105.
15. Dalakas, M.C, Leon-Monzon, M., Bernardini, I., Gahl, W.A. and Jay, C.A. (1994) Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann. Neurol., 35: 482-487.
16. Delaporte, C., Dautreaux, B. and Fardeau, M. (1986) Human myotube differentiation in vitro in different culture conditions. Biol. Cell; 57: 17-22.
17. Engbretson, B.G. (1996) Effect of zidovudine (AZT) on the structure and function of rat skeletal muscle. Can. J. Physiol. Pharmacol., 74: 679-686.
18. Faraj, A., Fowler, D.A., Bridges, E.G. and Sommadossi, J.P. (1994) Effects of 2′,3′-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis. Antimicrob. Ag. Chemother., 38: 924-930.
19. Feldman, D. and Anderson, T.D. (1994) Schwann cells mitochondrial alterations in peripheral nerves of rabbits treated with 2′,3′-dideoxycytidine. Acta Neuropathol., 87: 71-80.
20. Florini, J.R., Ewton, D.Z., Ferris, E. and Nadal-Ginard, B. (1988) Muscle cell cultures: Conditions for proliferation and differentiation of muscle cell cultures. In: Baserga, R. (ed.), Cell Growth and Division, A Practical Approach, IRL Press, Oxford, pp. 106-117.
21. Freshney, R.I. (1994) Measurement of viability and cytotoxicity. In: Freshney R.I. (ed.), Animal Cell Culture, 3rd edn., Wiley-Liss, New York, pp. 287-307.
22. Gabe, M. (1968) Détection histochimique des lipides et des composés apparentés. In: Techniques Histologiques, Masson, Paris, pp. 447-492.
23. Gosselin, G., Imbach, J.L. and Sommadossi, J.P. (1994) Antiviral nucleoside analogues and their bioactive phosphorylated metabolites: State of the art review of their detection and tissue monitoring applied to the anti-HIV drug AZT. Bull. Inst. Pasteur, 92: 181-196.
24. Grau, J.M., Masanes, F., Pedrol, E., Casademont, J., Fernandez-Sola, J. and Urbano-Marquez, A. (1993) Human immunodeficiency virus type 1 infection and myopathy: Clinical relevance of zidovudine therapy. Ann. Neurol., 34: 206-211.
25. Hatefi, Y. (1978) Preparation and properties of NADH-ubiquinone oxidoreductase (Complex I): NADH-ferricyanide reductase assay. Methods Enzymol., 53: 11-14.
26. Hayakawa, M., Ogawa, T., Sugiyama, S., Tanaka, M. and Ozawa, R. (1991) Massive conversion of guanosine to 8-hydroxyguanosine in mouse liver mitochondrial DNA by administration of azidothymidine. Biochem. Biophys. Res. Commun., 176: 87-93.
27. Herzberg, N.H., Zorn, I., Zwart, R., Portegies, P. and Bolhuis, RA. (1992) Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine. Muscle Nerve, 15: 706-710.
28. Hobbs, G.A., Keilbaugh, S.A., Rief, P.M. and Simpson, M.V. (1995) Cellular targets of 3′ azido-3′ deoxythymidine: An early (non-delayed) effect on oxidative phosphorylation. Biochem Pharmacol, 50: 381-390.
29. Lagord, C., Carpentier, G., Moraczewski, J., Pons, G., Climent, F. and Martelly, I. (1993) Satellite cell myogenesis is highly stimulated by the kinase inhibitor ISO-H7: Comparison with HA1004 and staurosporine effects. Biochem. Biophys. Res. Commun., 191: 928-936.
30. Lamperth, L., Dalakas, M.C., Dagani, F., Anderson, J. and Ferrari, R. (1991) Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab. Invest., 65: 742-751.
31. Lewis, W., Papoian, T., Gonzales, B. et al. (1991) Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab. Invest., 65: 228-236.
32. Lewis, W., Gonzalez, B., Chomyn, A. and Papoian, T. (1992) Zidovudine induces molecular, biochemical and ultrastructural changes in rat skeletal muscle mitochondria. J. Clin. Invest., 89: 1354-1360.
33. Lewis, W. and Dalakas, M.C. (1995) Mitochondrial toxicity of antiviral drugs. Nature Medicine, 1: 417-422.
34. Lowry, O.H, Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with the folin phenol. J. Biol. Chem., 193: 265-275.
35. Martin, J.L., Brown, C.E., Matthews-Davis, N. and Reardon, J.E. (1994) Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob. Ag. Chemother., 38: 2743-2749.
36. Mhiri, C., Baudrimont, M., Bonne, G. et al. (1991) Zidovudine myopathy: A distinctive disorder associated with mitochondrial dysfunction. Ann. Neurol. 29: 606-614.
37. Reyes, M.G., Casanova, J., Varriccio, F., Sequeira, W. and Fresco, K. (1992) Zidovudine myopathy. Neurology, 42: 1252.
38. Robinson, J.B., Brent, L.G., Sumegi, B. and Srere, P.A. (1987) An enzymatic approach to the study of the Krebs tricarboxylic acid cycle. In: Darley-Usmar, V.M., Rickwood, D. and Wilson, M.T. (eds.), Mitochondria, a Practical Approach, IRL Press, Oxford, pp. 153-170.
39. Semino-Mora, M.C., Leon-Monzon, M.E. and Dalakas, M.C. (1994a) Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro. Lab. Invest, 71: 102-112.
40. Semino-Mora, M.C., Leon-Monzon, M.E. and Dalakas, M.C. (1994b) The effect of L-carnitine on the AZT-induced destruction of human myotubes. Part II: Treatment with L-carnitine improves the AZT-induced changes and prevents further destruction. Lab. Invest., 71: 773-781.
41. Srere, A. (1969) Citrate synthase. Methods Enzymol., 13: 3-11.
42. Yarchoan, R., Mitsuya, H., Myers C.E. and Broder, S. (1989) Clinical pharmacology of 3′-azido-2′3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. N. Engl. J. Med., 321: 726-738.
43. Yarchoan, R., Pluda, J.M., Thomas, R.V. et al. (1990) Long-term toxicity/ activity profile of 2′,3′-dideoxyinosine in AIDS or AIDS-related complex. Lancet, 336: 526-529.